Immunization safety review :: hepatitis B vaccine and demyelinating neurological disorders /
Immunization to protect infants and children from vaccine-preventable diseases is one of the greatest achievements of public health. Immunization is not without risks, however. It is well established, for example, that the oral polio vaccine can on rare occasion cause paralytic polio.The Immunizatio...
Gespeichert in:
Weitere Verfasser: | , , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Washington, D.C. ; [Great Britain] :
National Academies Press,
©2002.
|
Schlagworte: | |
Online-Zugang: | Volltext |
Zusammenfassung: | Immunization to protect infants and children from vaccine-preventable diseases is one of the greatest achievements of public health. Immunization is not without risks, however. It is well established, for example, that the oral polio vaccine can on rare occasion cause paralytic polio.The Immunization Safety Review Committee was established by the Institute of Medicine (IOM) to evaluate the available evidence on a series of immunization safety concerns. The committee is charged with examining three immunization safety hypotheses each year during the three-year study period (2001- 2003). While all of the committee members share the view that immunization is generally beneficial, none of them has a vested interest in the specific immunization safety issues that come before the group. In this report, which is the fourth in the series, the committee examines the hypothesis that the hepatitis B vaccine increases the risk for demyelinating disorders of the central or peripheral nervous systems, including multiple sclerosis (MS) and Guillain-Barr syndrome (GBS). |
Beschreibung: | 1 online resource (xiv, 106 pages :) |
Format: | Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |
Bibliographie: | Includes bibliographical references (pages 85-90). |
ISBN: | 030956610X 9780309566100 1280183551 9781280183553 9786610183555 6610183554 0309182832 9780309182836 |
Internformat
MARC
LEADER | 00000cam a2200000Ma 4500 | ||
---|---|---|---|
001 | ZDB-4-EBA-ocm70734600 | ||
003 | OCoLC | ||
005 | 20240705115654.0 | ||
006 | m o d | ||
007 | cr cn||||||||| | ||
008 | 040120s2002 enka ob 000 0 eng d | ||
010 | |z 2003544621 | ||
040 | |a REDDC |b eng |e pn |c REDDC |d OCLCQ |d DKDLA |d MERUC |d CCO |d OCLCE |d E7B |d IDEBK |d OCLCQ |d N$T |d YDXCP |d COF |d GPM |d ORU |d FVL |d OCLCQ |d ORU |d OCLCQ |d NLGGC |d OCLCQ |d EBLCP |d OCLCQ |d AZK |d TOA |d MOR |d PIFBR |d ZCU |d XFH |d MERER |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d OCLCA |d BUF |d OCLCO |d CUY |d U3W |d OCLCO |d OCLCF |d OCLCQ |d OCLCO |d STF |d VNS |d WRM |d VTS |d NRAMU |d EZ9 |d OCLCQ |d ICG |d VT2 |d AU@ |d OCLCQ |d OCLCO |d WYU |d TKN |d G3B |d OCLCO |d DKC |d OCLCQ |d OCLCA |d HS0 |d KIJ |d SFB |d OCLCQ |d OCLCA |d UKBTH |d INARC |d QGK |d DST |d OCLCO |d OCLCQ |d OCL |d OCLCO |d OCLCL | ||
015 | |a GBA376793 |2 bnb | ||
015 | |a GBA3-76793 | ||
016 | 7 | |a 101166764 |2 DNLM | |
019 | |a 57000328 |a 474062845 |a 475648702 |a 559227104 |a 606930927 |a 609225739 |a 666925091 |a 722314380 |a 728020442 |a 923269360 |a 961496580 |a 962701558 |a 988451823 |a 991941186 |a 994444859 |a 1028776767 |a 1037911322 |a 1038643924 |a 1045487562 |a 1047541667 |a 1055341038 |a 1062863061 |a 1109241583 |a 1136331917 |a 1144299751 |a 1156389607 |a 1159643831 |a 1193950381 |a 1204393531 |a 1227629720 |a 1228559120 |a 1259223537 |a 1290031973 |a 1300527971 |a 1303303403 |a 1303517603 |a 1306577746 |a 1329062557 |a 1424874775 | ||
020 | |a 030956610X |q (electronic bk.) | ||
020 | |a 9780309566100 |q (electronic bk.) | ||
020 | |z 0309084695 |q (pbk.) | ||
020 | |z 9780309084697 |q (pbk.) | ||
020 | |a 1280183551 | ||
020 | |a 9781280183553 | ||
020 | |a 9786610183555 | ||
020 | |a 6610183554 | ||
020 | |a 0309182832 | ||
020 | |a 9780309182836 | ||
020 | |z 0309385105 | ||
020 | |z 9780309385107 | ||
035 | |a (OCoLC)70734600 |z (OCoLC)57000328 |z (OCoLC)474062845 |z (OCoLC)475648702 |z (OCoLC)559227104 |z (OCoLC)606930927 |z (OCoLC)609225739 |z (OCoLC)666925091 |z (OCoLC)722314380 |z (OCoLC)728020442 |z (OCoLC)923269360 |z (OCoLC)961496580 |z (OCoLC)962701558 |z (OCoLC)988451823 |z (OCoLC)991941186 |z (OCoLC)994444859 |z (OCoLC)1028776767 |z (OCoLC)1037911322 |z (OCoLC)1038643924 |z (OCoLC)1045487562 |z (OCoLC)1047541667 |z (OCoLC)1055341038 |z (OCoLC)1062863061 |z (OCoLC)1109241583 |z (OCoLC)1136331917 |z (OCoLC)1144299751 |z (OCoLC)1156389607 |z (OCoLC)1159643831 |z (OCoLC)1193950381 |z (OCoLC)1204393531 |z (OCoLC)1227629720 |z (OCoLC)1228559120 |z (OCoLC)1259223537 |z (OCoLC)1290031973 |z (OCoLC)1300527971 |z (OCoLC)1303303403 |z (OCoLC)1303517603 |z (OCoLC)1306577746 |z (OCoLC)1329062557 |z (OCoLC)1424874775 | ||
042 | |a dlr | ||
043 | |a n-us--- | ||
050 | 4 | |a QR189.5.H46 |b I45 2002eb | |
060 | 4 | |a 2003 B-668 | |
060 | 4 | |a WC 536 |b I325 2002 | |
072 | 7 | |a MED |x 071000 |2 bisacsh | |
072 | 7 | |a MBP |2 bicssc | |
072 | 7 | |a MBN |2 bicssc | |
082 | 7 | |a 614.593 |2 22 | |
049 | |a MAIN | ||
245 | 0 | 0 | |a Immunization safety review : |b hepatitis B vaccine and demyelinating neurological disorders / |c Kathleen Stratton, Donna A. Almario, and Marie C. McCormick, editors. |
260 | |a Washington, D.C. ; |a [Great Britain] : |b National Academies Press, |c ©2002. | ||
300 | |a 1 online resource (xiv, 106 pages :) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
347 | |a data file |2 rda | ||
504 | |a Includes bibliographical references (pages 85-90). | ||
588 | 0 | |a Print version record. | |
506 | |3 Use copy |f Restrictions unspecified |2 star |5 MiAaHDL | ||
533 | |a Electronic reproduction. |b [S.l.] : |c HathiTrust Digital Library, |d 2010. |5 MiAaHDL | ||
538 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |u http://purl.oclc.org/DLF/benchrepro0212 |5 MiAaHDL | ||
583 | 1 | |a digitized |c 2010 |h HathiTrust Digital Library |l committed to preserve |2 pda |5 MiAaHDL | |
505 | 0 | |a ""IMMUNIZATION SAFETY REVIEW""; ""Copyright""; ""Acknowledgments""; ""Contents""; ""Executive Summary""; ""ABSTRACT""; ""DEMYELINATING NEUROLOGICAL DISORDERS""; ""HEPATITIS B VIRAL INFECTION""; ""HEPATITIS B VACCINE""; ""EVIDENCE REVIEWED BY THE COMMITTEE""; ""CAUSALITY ASSESSMENT""; ""BIOLOGICAL MECHANISMS ASSESSMENT""; ""SIGNIFICANCE ASSESSMENT""; ""RECOMMENDATIONS FOR PUBLIC HEALTH RESPONSE""; ""Policy Review""; ""Research""; ""Surveillance""; ""Basic and Clinical Science""; ""Communication""; ""REFERENCES"" | |
505 | 8 | |a ""Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders""""THE CHARGE TO THE COMMITTEE""; ""THE STUDY PROCESS""; ""THE FRAMEWORK FOR SCIENTIFIC ASSESSMENT""; ""Causality""; ""Biological Mechanisms""; ""Terminology""; ""Categories of Evidence""; ""Published and Unpublished Data""; ""UNDER REVIEW: HEPATITIS B VACCINE AND DEMYELINATING NEUROLOGICAL DISORDERS""; ""Adverse Neurological Events""; ""Multiple Sclerosis""; ""Acute Disseminated Encephalomyelitis""; ""Optic Neuritis""; ""Transverse Myelitis""; ""Guillain-Barré Syndrome""; ""Peripheral Neuritis"" | |
505 | 8 | |a ""Hepatitis B Virus Infection and Hepatitis B Vaccines""""SCIENTIFIC ASSESSMENT""; ""Causality""; ""Case Reports""; ""Multiple Sclerosis""; ""Causality Argument""; ""First Episode of a Central Nervous System Demyelinating Disorder""; ""Acute Disseminated Encephalomyelitis""; ""Optic Neuritis""; ""Transverse Myelitis""; ""Brachial Neuritis""; ""Biological Mechanisms""; ""Immune-Mediated Processes in MS and Other Demyelinating White-Matter Diseases""; ""Theoretical Mechanisms for Infection-Induced Immune-Mediated Injury""; ""Theoretical Mechanisms for Vaccine-Induced Demyelinating Diseases"" | |
505 | 8 | |a ""Evidence from Animal Models for a Possible Role for Hepatitis B Vaccine in Demyelination""""Evidence from Humans""; ""Known Effects of Other Vaccines""; ""Conclusions Regarding Biological Mechanisms""; ""SIGNIFICANCE ASSESSMENT""; ""Disease Burden Associated with Multiple Sclerosis""; ""Hepatitis B Vaccine Safety Concerns in France""; ""Hepatitis B Virus Infection""; ""Prevention Strategies""; ""Acceptance of the Hepatitis B Vaccine in the United States""; ""Information on the Safety of the Hepatitis B Vaccine""; ""Conclusions""; ""RECOMMENDATIONS FOR PUBLIC HEALTH RESPONSE"" | |
505 | 8 | |a ""Policy Review""""Research""; ""Surveillance""; ""Basic and Clinical Science""; ""Communication""; ""SUMMARY""; ""REFERENCES""; ""Appendix A Committee Conclusions and Recommendations from Previous Reports ""; ""MEASLES-MUMPS-RUBELLA VACCINE AND AUTISM""; ""Conclusions""; ""Recommendations""; ""Public Health Response""; ""Policy Review""; ""Research Regarding MMR and ASD""; ""Communications""; ""THIMEROSAL-CONTAINING VACCINES AND NEURODEVELOPMENTAL DISORDERS""; ""Conclusions""; ""Public Health Response Recommendations""; ""Policy Review and Analysis"" | |
546 | |a English. | ||
520 | |a Immunization to protect infants and children from vaccine-preventable diseases is one of the greatest achievements of public health. Immunization is not without risks, however. It is well established, for example, that the oral polio vaccine can on rare occasion cause paralytic polio.The Immunization Safety Review Committee was established by the Institute of Medicine (IOM) to evaluate the available evidence on a series of immunization safety concerns. The committee is charged with examining three immunization safety hypotheses each year during the three-year study period (2001- 2003). While all of the committee members share the view that immunization is generally beneficial, none of them has a vested interest in the specific immunization safety issues that come before the group. In this report, which is the fourth in the series, the committee examines the hypothesis that the hepatitis B vaccine increases the risk for demyelinating disorders of the central or peripheral nervous systems, including multiple sclerosis (MS) and Guillain-Barr syndrome (GBS). | ||
650 | 0 | |a Hepatitis B |x Vaccination. |0 http://id.loc.gov/authorities/subjects/sh85060296 | |
650 | 0 | |a Hepatitis B vaccine. |0 http://id.loc.gov/authorities/subjects/sh85060297 | |
650 | 0 | |a Demyelination |x Vaccination. | |
650 | 0 | |a Immunization |x Complications. |0 http://id.loc.gov/authorities/subjects/sh88000677 | |
650 | 0 | |a Vaccination |x Complications. |0 http://id.loc.gov/authorities/subjects/sh85141710 | |
650 | 0 | |a Medical policy. |0 http://id.loc.gov/authorities/subjects/sh85083002 | |
650 | 0 | |a Demyelination. |0 http://id.loc.gov/authorities/subjects/sh85036687 | |
650 | 0 | |a Nervous system |x Diseases. |0 http://id.loc.gov/authorities/subjects/sh85090924 | |
650 | 0 | |a Viral vaccines. |0 http://id.loc.gov/authorities/subjects/sh85143735 | |
650 | 0 | |a Diseases. |0 http://id.loc.gov/authorities/subjects/sh85038411 | |
650 | 0 | |a Vaccines. |0 http://id.loc.gov/authorities/subjects/sh85141718 | |
650 | 0 | |a Social control. |0 http://id.loc.gov/authorities/subjects/sh85123931 | |
650 | 0 | |a Social sciences. |0 http://id.loc.gov/authorities/subjects/sh85124003 | |
650 | 0 | |a Sociology. |0 http://id.loc.gov/authorities/subjects/sh85124200 | |
650 | 0 | |a Medical care. |0 http://id.loc.gov/authorities/subjects/sh85082871 | |
651 | 0 | |a North America. |0 http://id.loc.gov/authorities/subjects/sh85092455 | |
650 | 0 | |a Biologicals. |0 http://id.loc.gov/authorities/subjects/sh90002675 | |
650 | 0 | |a Biological products. |0 http://id.loc.gov/authorities/subjects/sh85014183 | |
650 | 2 | |a Hepatitis B Vaccines |x adverse effects | |
650 | 2 | |a Demyelinating Diseases |x etiology | |
650 | 2 | |a Health Policy | |
650 | 2 | |a Biological Products | |
650 | 2 | |a Demyelinating Diseases | |
650 | 2 | |a Hepatitis B Vaccines | |
650 | 2 | |a Public Policy | |
650 | 2 | |a Nervous System Diseases | |
650 | 2 | |a Viral Hepatitis Vaccines | |
650 | 2 | |a Social Control Policies | |
650 | 2 | |a Viral Vaccines | |
650 | 2 | |a Disease | |
650 | 2 | |a Americas. | |
650 | 2 | |a Policy | |
650 | 2 | |a Vaccines | |
650 | 2 | |a Geographic Locations. | |
650 | 2 | |a Social Control, Formal | |
650 | 2 | |a Health Care Economics and Organizations. | |
650 | 2 | |a Social Sciences | |
650 | 2 | |a Geographicals. | |
650 | 2 | |a Sociology | |
650 | 2 | |a Delivery of Health Care | |
650 | 2 | |a Complex Mixtures | |
650 | 2 | |a Anthropology, Education, Sociology and Social Phenomena. | |
650 | 2 | |a Chemicals and Drugs. | |
650 | 2 | |a Biological Factors | |
651 | 2 | |a United States | |
651 | 2 | |a North America | |
650 | 2 | |a Vaccination |x adverse effects |0 https://id.nlm.nih.gov/mesh/D014611Q000009 | |
650 | 2 | |a Patient Care |0 https://id.nlm.nih.gov/mesh/D005791 | |
650 | 6 | |a Hépatite B |x Vaccination. | |
650 | 6 | |a Vaccin anti-hépatite B. | |
650 | 6 | |a Démyélinisation |x Vaccination. | |
650 | 6 | |a Vaccination |x Complications et séquelles. | |
650 | 6 | |a Politique sanitaire. | |
650 | 6 | |a Démyélinisation. | |
650 | 6 | |a Système nerveux |x Maladies. | |
650 | 6 | |a Vaccins antiviraux. | |
650 | 6 | |a Maladies. | |
650 | 6 | |a Vaccins. | |
650 | 6 | |a Contrôle social. | |
650 | 6 | |a Sciences sociales. | |
650 | 6 | |a Sociologie. | |
650 | 6 | |a Prestation de soins. | |
650 | 6 | |a Produits biologiques. | |
651 | 6 | |a Amérique du Nord. | |
650 | 6 | |a Immunisation |x Complications et séquelles. | |
650 | 6 | |a Soins médicaux. | |
650 | 6 | |a Médicaments biologiques. | |
650 | 7 | |a social sciences. |2 aat | |
650 | 7 | |a sociology. |2 aat | |
650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
650 | 7 | |a Viral vaccines |2 fast | |
650 | 7 | |a Vaccines |2 fast | |
650 | 7 | |a Sociology |2 fast | |
650 | 7 | |a Social sciences |2 fast | |
650 | 7 | |a Social control |2 fast | |
650 | 7 | |a Nervous system |x Diseases |2 fast | |
650 | 7 | |a Medical policy |2 fast | |
650 | 7 | |a Medical care |2 fast | |
650 | 7 | |a Diseases |2 fast | |
650 | 7 | |a Demyelination |2 fast | |
650 | 7 | |a Hepatitis B |x Vaccination |2 fast | |
650 | 7 | |a Hepatitis B vaccine |2 fast | |
650 | 7 | |a Immunization |x Complications |2 fast | |
650 | 7 | |a Vaccination |x Complications |2 fast | |
651 | 7 | |a North America |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJxRHKPqWyj6g89H9PwHmd | |
653 | |a Andre fag (naturvidenskab og teknik) |a Andre fag | ||
655 | 0 | |a Electronic book. | |
700 | 1 | |a Stratton, Kathleen R. |0 http://id.loc.gov/authorities/names/n93803579 | |
700 | 1 | |a Almario, Donna A. |0 http://id.loc.gov/authorities/names/n98091055 | |
700 | 1 | |a McCormick, Marie C. |0 http://id.loc.gov/authorities/names/n98091060 | |
758 | |i has work: |a Immunization safety review (Text) |1 https://id.oclc.org/worldcat/entity/E39PCG8V97gpM96WHMKtKh7HBX |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
776 | 0 | 8 | |i Print version: |t Immunization safety review. |d Washington, D.C. ; [Great Britain] : National Academies Press, ©2002 |w (DLC) 2003544621 |
856 | 1 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=121296 |3 Volltext | |
856 | 1 | |l CBO01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=121296 |3 Volltext | |
938 | |a EBL - Ebook Library |b EBLB |n EBL3377265 | ||
938 | |a ebrary |b EBRY |n ebr10068512 | ||
938 | |a EBSCOhost |b EBSC |n 121296 | ||
938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 18355 | ||
938 | |a YBP Library Services |b YANK |n 2293654 | ||
938 | |a Internet Archive |b INAR |n immunizationsafe0000unse_a2n1 | ||
994 | |a 92 |b GEBAY | ||
912 | |a ZDB-4-EBA |
Datensatz im Suchindex
DE-BY-FWS_katkey | ZDB-4-EBA-ocm70734600 |
---|---|
_version_ | 1813903292200124417 |
adam_text | |
any_adam_object | |
author2 | Stratton, Kathleen R. Almario, Donna A. McCormick, Marie C. |
author2_role | |
author2_variant | k r s kr krs d a a da daa m c m mc mcm |
author_GND | http://id.loc.gov/authorities/names/n93803579 http://id.loc.gov/authorities/names/n98091055 http://id.loc.gov/authorities/names/n98091060 |
author_facet | Stratton, Kathleen R. Almario, Donna A. McCormick, Marie C. |
author_sort | Stratton, Kathleen R. |
building | Verbundindex |
bvnumber | localFWS |
callnumber-first | Q - Science |
callnumber-label | QR189 |
callnumber-raw | QR189.5.H46 I45 2002eb |
callnumber-search | QR189.5.H46 I45 2002eb |
callnumber-sort | QR 3189.5 H46 I45 42002EB |
callnumber-subject | QR - Microbiology |
collection | ZDB-4-EBA |
contents | ""IMMUNIZATION SAFETY REVIEW""; ""Copyright""; ""Acknowledgments""; ""Contents""; ""Executive Summary""; ""ABSTRACT""; ""DEMYELINATING NEUROLOGICAL DISORDERS""; ""HEPATITIS B VIRAL INFECTION""; ""HEPATITIS B VACCINE""; ""EVIDENCE REVIEWED BY THE COMMITTEE""; ""CAUSALITY ASSESSMENT""; ""BIOLOGICAL MECHANISMS ASSESSMENT""; ""SIGNIFICANCE ASSESSMENT""; ""RECOMMENDATIONS FOR PUBLIC HEALTH RESPONSE""; ""Policy Review""; ""Research""; ""Surveillance""; ""Basic and Clinical Science""; ""Communication""; ""REFERENCES"" ""Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders""""THE CHARGE TO THE COMMITTEE""; ""THE STUDY PROCESS""; ""THE FRAMEWORK FOR SCIENTIFIC ASSESSMENT""; ""Causality""; ""Biological Mechanisms""; ""Terminology""; ""Categories of Evidence""; ""Published and Unpublished Data""; ""UNDER REVIEW: HEPATITIS B VACCINE AND DEMYELINATING NEUROLOGICAL DISORDERS""; ""Adverse Neurological Events""; ""Multiple Sclerosis""; ""Acute Disseminated Encephalomyelitis""; ""Optic Neuritis""; ""Transverse Myelitis""; ""Guillain-Barré Syndrome""; ""Peripheral Neuritis"" ""Hepatitis B Virus Infection and Hepatitis B Vaccines""""SCIENTIFIC ASSESSMENT""; ""Causality""; ""Case Reports""; ""Multiple Sclerosis""; ""Causality Argument""; ""First Episode of a Central Nervous System Demyelinating Disorder""; ""Acute Disseminated Encephalomyelitis""; ""Optic Neuritis""; ""Transverse Myelitis""; ""Brachial Neuritis""; ""Biological Mechanisms""; ""Immune-Mediated Processes in MS and Other Demyelinating White-Matter Diseases""; ""Theoretical Mechanisms for Infection-Induced Immune-Mediated Injury""; ""Theoretical Mechanisms for Vaccine-Induced Demyelinating Diseases"" ""Evidence from Animal Models for a Possible Role for Hepatitis B Vaccine in Demyelination""""Evidence from Humans""; ""Known Effects of Other Vaccines""; ""Conclusions Regarding Biological Mechanisms""; ""SIGNIFICANCE ASSESSMENT""; ""Disease Burden Associated with Multiple Sclerosis""; ""Hepatitis B Vaccine Safety Concerns in France""; ""Hepatitis B Virus Infection""; ""Prevention Strategies""; ""Acceptance of the Hepatitis B Vaccine in the United States""; ""Information on the Safety of the Hepatitis B Vaccine""; ""Conclusions""; ""RECOMMENDATIONS FOR PUBLIC HEALTH RESPONSE"" ""Policy Review""""Research""; ""Surveillance""; ""Basic and Clinical Science""; ""Communication""; ""SUMMARY""; ""REFERENCES""; ""Appendix A Committee Conclusions and Recommendations from Previous Reports ""; ""MEASLES-MUMPS-RUBELLA VACCINE AND AUTISM""; ""Conclusions""; ""Recommendations""; ""Public Health Response""; ""Policy Review""; ""Research Regarding MMR and ASD""; ""Communications""; ""THIMEROSAL-CONTAINING VACCINES AND NEURODEVELOPMENTAL DISORDERS""; ""Conclusions""; ""Public Health Response Recommendations""; ""Policy Review and Analysis"" |
ctrlnum | (OCoLC)70734600 |
dewey-full | 614.593 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 614 - Forensic medicine; incidence of disease |
dewey-raw | 614.593 |
dewey-search | 614.593 |
dewey-sort | 3614.593 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>13184cam a2201885Ma 4500</leader><controlfield tag="001">ZDB-4-EBA-ocm70734600 </controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20240705115654.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">040120s2002 enka ob 000 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="z"> 2003544621</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">REDDC</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">REDDC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">DKDLA</subfield><subfield code="d">MERUC</subfield><subfield code="d">CCO</subfield><subfield code="d">OCLCE</subfield><subfield code="d">E7B</subfield><subfield code="d">IDEBK</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">N$T</subfield><subfield code="d">YDXCP</subfield><subfield code="d">COF</subfield><subfield code="d">GPM</subfield><subfield code="d">ORU</subfield><subfield code="d">FVL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">ORU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">NLGGC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AZK</subfield><subfield code="d">TOA</subfield><subfield code="d">MOR</subfield><subfield code="d">PIFBR</subfield><subfield code="d">ZCU</subfield><subfield code="d">XFH</subfield><subfield code="d">MERER</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">BUF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">CUY</subfield><subfield code="d">U3W</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">STF</subfield><subfield code="d">VNS</subfield><subfield code="d">WRM</subfield><subfield code="d">VTS</subfield><subfield code="d">NRAMU</subfield><subfield code="d">EZ9</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">ICG</subfield><subfield code="d">VT2</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">WYU</subfield><subfield code="d">TKN</subfield><subfield code="d">G3B</subfield><subfield code="d">OCLCO</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">HS0</subfield><subfield code="d">KIJ</subfield><subfield code="d">SFB</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">UKBTH</subfield><subfield code="d">INARC</subfield><subfield code="d">QGK</subfield><subfield code="d">DST</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">GBA376793</subfield><subfield code="2">bnb</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">GBA3-76793</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">101166764</subfield><subfield code="2">DNLM</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">57000328</subfield><subfield code="a">474062845</subfield><subfield code="a">475648702</subfield><subfield code="a">559227104</subfield><subfield code="a">606930927</subfield><subfield code="a">609225739</subfield><subfield code="a">666925091</subfield><subfield code="a">722314380</subfield><subfield code="a">728020442</subfield><subfield code="a">923269360</subfield><subfield code="a">961496580</subfield><subfield code="a">962701558</subfield><subfield code="a">988451823</subfield><subfield code="a">991941186</subfield><subfield code="a">994444859</subfield><subfield code="a">1028776767</subfield><subfield code="a">1037911322</subfield><subfield code="a">1038643924</subfield><subfield code="a">1045487562</subfield><subfield code="a">1047541667</subfield><subfield code="a">1055341038</subfield><subfield code="a">1062863061</subfield><subfield code="a">1109241583</subfield><subfield code="a">1136331917</subfield><subfield code="a">1144299751</subfield><subfield code="a">1156389607</subfield><subfield code="a">1159643831</subfield><subfield code="a">1193950381</subfield><subfield code="a">1204393531</subfield><subfield code="a">1227629720</subfield><subfield code="a">1228559120</subfield><subfield code="a">1259223537</subfield><subfield code="a">1290031973</subfield><subfield code="a">1300527971</subfield><subfield code="a">1303303403</subfield><subfield code="a">1303517603</subfield><subfield code="a">1306577746</subfield><subfield code="a">1329062557</subfield><subfield code="a">1424874775</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">030956610X</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309566100</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309084695</subfield><subfield code="q">(pbk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309084697</subfield><subfield code="q">(pbk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1280183551</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781280183553</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9786610183555</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">6610183554</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309182832</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309182836</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309385105</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309385107</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)70734600</subfield><subfield code="z">(OCoLC)57000328</subfield><subfield code="z">(OCoLC)474062845</subfield><subfield code="z">(OCoLC)475648702</subfield><subfield code="z">(OCoLC)559227104</subfield><subfield code="z">(OCoLC)606930927</subfield><subfield code="z">(OCoLC)609225739</subfield><subfield code="z">(OCoLC)666925091</subfield><subfield code="z">(OCoLC)722314380</subfield><subfield code="z">(OCoLC)728020442</subfield><subfield code="z">(OCoLC)923269360</subfield><subfield code="z">(OCoLC)961496580</subfield><subfield code="z">(OCoLC)962701558</subfield><subfield code="z">(OCoLC)988451823</subfield><subfield code="z">(OCoLC)991941186</subfield><subfield code="z">(OCoLC)994444859</subfield><subfield code="z">(OCoLC)1028776767</subfield><subfield code="z">(OCoLC)1037911322</subfield><subfield code="z">(OCoLC)1038643924</subfield><subfield code="z">(OCoLC)1045487562</subfield><subfield code="z">(OCoLC)1047541667</subfield><subfield code="z">(OCoLC)1055341038</subfield><subfield code="z">(OCoLC)1062863061</subfield><subfield code="z">(OCoLC)1109241583</subfield><subfield code="z">(OCoLC)1136331917</subfield><subfield code="z">(OCoLC)1144299751</subfield><subfield code="z">(OCoLC)1156389607</subfield><subfield code="z">(OCoLC)1159643831</subfield><subfield code="z">(OCoLC)1193950381</subfield><subfield code="z">(OCoLC)1204393531</subfield><subfield code="z">(OCoLC)1227629720</subfield><subfield code="z">(OCoLC)1228559120</subfield><subfield code="z">(OCoLC)1259223537</subfield><subfield code="z">(OCoLC)1290031973</subfield><subfield code="z">(OCoLC)1300527971</subfield><subfield code="z">(OCoLC)1303303403</subfield><subfield code="z">(OCoLC)1303517603</subfield><subfield code="z">(OCoLC)1306577746</subfield><subfield code="z">(OCoLC)1329062557</subfield><subfield code="z">(OCoLC)1424874775</subfield></datafield><datafield tag="042" ind1=" " ind2=" "><subfield code="a">dlr</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">n-us---</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QR189.5.H46</subfield><subfield code="b">I45 2002eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">2003 B-668</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">WC 536</subfield><subfield code="b">I325 2002</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">071000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MBP</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MBN</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">614.593</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Immunization safety review :</subfield><subfield code="b">hepatitis B vaccine and demyelinating neurological disorders /</subfield><subfield code="c">Kathleen Stratton, Donna A. Almario, and Marie C. McCormick, editors.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Washington, D.C. ;</subfield><subfield code="a">[Great Britain] :</subfield><subfield code="b">National Academies Press,</subfield><subfield code="c">©2002.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xiv, 106 pages :)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">data file</subfield><subfield code="2">rda</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (pages 85-90).</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="506" ind1=" " ind2=" "><subfield code="3">Use copy</subfield><subfield code="f">Restrictions unspecified</subfield><subfield code="2">star</subfield><subfield code="5">MiAaHDL</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Electronic reproduction.</subfield><subfield code="b">[S.l.] :</subfield><subfield code="c">HathiTrust Digital Library,</subfield><subfield code="d">2010.</subfield><subfield code="5">MiAaHDL</subfield></datafield><datafield tag="538" ind1=" " ind2=" "><subfield code="a">Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.</subfield><subfield code="u">http://purl.oclc.org/DLF/benchrepro0212</subfield><subfield code="5">MiAaHDL</subfield></datafield><datafield tag="583" ind1="1" ind2=" "><subfield code="a">digitized</subfield><subfield code="c">2010</subfield><subfield code="h">HathiTrust Digital Library</subfield><subfield code="l">committed to preserve</subfield><subfield code="2">pda</subfield><subfield code="5">MiAaHDL</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">""IMMUNIZATION SAFETY REVIEW""; ""Copyright""; ""Acknowledgments""; ""Contents""; ""Executive Summary""; ""ABSTRACT""; ""DEMYELINATING NEUROLOGICAL DISORDERS""; ""HEPATITIS B VIRAL INFECTION""; ""HEPATITIS B VACCINE""; ""EVIDENCE REVIEWED BY THE COMMITTEE""; ""CAUSALITY ASSESSMENT""; ""BIOLOGICAL MECHANISMS ASSESSMENT""; ""SIGNIFICANCE ASSESSMENT""; ""RECOMMENDATIONS FOR PUBLIC HEALTH RESPONSE""; ""Policy Review""; ""Research""; ""Surveillance""; ""Basic and Clinical Science""; ""Communication""; ""REFERENCES""</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">""Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders""""THE CHARGE TO THE COMMITTEE""; ""THE STUDY PROCESS""; ""THE FRAMEWORK FOR SCIENTIFIC ASSESSMENT""; ""Causality""; ""Biological Mechanisms""; ""Terminology""; ""Categories of Evidence""; ""Published and Unpublished Data""; ""UNDER REVIEW: HEPATITIS B VACCINE AND DEMYELINATING NEUROLOGICAL DISORDERS""; ""Adverse Neurological Events""; ""Multiple Sclerosis""; ""Acute Disseminated Encephalomyelitis""; ""Optic Neuritis""; ""Transverse Myelitis""; ""Guillain-Barré Syndrome""; ""Peripheral Neuritis""</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">""Hepatitis B Virus Infection and Hepatitis B Vaccines""""SCIENTIFIC ASSESSMENT""; ""Causality""; ""Case Reports""; ""Multiple Sclerosis""; ""Causality Argument""; ""First Episode of a Central Nervous System Demyelinating Disorder""; ""Acute Disseminated Encephalomyelitis""; ""Optic Neuritis""; ""Transverse Myelitis""; ""Brachial Neuritis""; ""Biological Mechanisms""; ""Immune-Mediated Processes in MS and Other Demyelinating White-Matter Diseases""; ""Theoretical Mechanisms for Infection-Induced Immune-Mediated Injury""; ""Theoretical Mechanisms for Vaccine-Induced Demyelinating Diseases""</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">""Evidence from Animal Models for a Possible Role for Hepatitis B Vaccine in Demyelination""""Evidence from Humans""; ""Known Effects of Other Vaccines""; ""Conclusions Regarding Biological Mechanisms""; ""SIGNIFICANCE ASSESSMENT""; ""Disease Burden Associated with Multiple Sclerosis""; ""Hepatitis B Vaccine Safety Concerns in France""; ""Hepatitis B Virus Infection""; ""Prevention Strategies""; ""Acceptance of the Hepatitis B Vaccine in the United States""; ""Information on the Safety of the Hepatitis B Vaccine""; ""Conclusions""; ""RECOMMENDATIONS FOR PUBLIC HEALTH RESPONSE""</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">""Policy Review""""Research""; ""Surveillance""; ""Basic and Clinical Science""; ""Communication""; ""SUMMARY""; ""REFERENCES""; ""Appendix A Committee Conclusions and Recommendations from Previous Reports ""; ""MEASLES-MUMPS-RUBELLA VACCINE AND AUTISM""; ""Conclusions""; ""Recommendations""; ""Public Health Response""; ""Policy Review""; ""Research Regarding MMR and ASD""; ""Communications""; ""THIMEROSAL-CONTAINING VACCINES AND NEURODEVELOPMENTAL DISORDERS""; ""Conclusions""; ""Public Health Response Recommendations""; ""Policy Review and Analysis""</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Immunization to protect infants and children from vaccine-preventable diseases is one of the greatest achievements of public health. Immunization is not without risks, however. It is well established, for example, that the oral polio vaccine can on rare occasion cause paralytic polio.The Immunization Safety Review Committee was established by the Institute of Medicine (IOM) to evaluate the available evidence on a series of immunization safety concerns. The committee is charged with examining three immunization safety hypotheses each year during the three-year study period (2001- 2003). While all of the committee members share the view that immunization is generally beneficial, none of them has a vested interest in the specific immunization safety issues that come before the group. In this report, which is the fourth in the series, the committee examines the hypothesis that the hepatitis B vaccine increases the risk for demyelinating disorders of the central or peripheral nervous systems, including multiple sclerosis (MS) and Guillain-Barr syndrome (GBS).</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Hepatitis B</subfield><subfield code="x">Vaccination.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85060296</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Hepatitis B vaccine.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85060297</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Demyelination</subfield><subfield code="x">Vaccination.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Immunization</subfield><subfield code="x">Complications.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh88000677</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Vaccination</subfield><subfield code="x">Complications.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85141710</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical policy.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85083002</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Demyelination.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85036687</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Nervous system</subfield><subfield code="x">Diseases.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85090924</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Viral vaccines.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85143735</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Diseases.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85038411</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Vaccines.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85141718</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Social control.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85123931</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Social sciences.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85124003</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Sociology.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85124200</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical care.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85082871</subfield></datafield><datafield tag="651" ind1=" " ind2="0"><subfield code="a">North America.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85092455</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Biologicals.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh90002675</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Biological products.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85014183</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Hepatitis B Vaccines</subfield><subfield code="x">adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Demyelinating Diseases</subfield><subfield code="x">etiology</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Health Policy</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Biological Products</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Demyelinating Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Hepatitis B Vaccines</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Public Policy</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Nervous System Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Viral Hepatitis Vaccines</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Social Control Policies</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Viral Vaccines</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Disease</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Americas.</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Policy</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Vaccines</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Geographic Locations.</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Social Control, Formal</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Health Care Economics and Organizations.</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Social Sciences</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Geographicals.</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Sociology</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Delivery of Health Care</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Complex Mixtures</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Anthropology, Education, Sociology and Social Phenomena.</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Chemicals and Drugs.</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Biological Factors</subfield></datafield><datafield tag="651" ind1=" " ind2="2"><subfield code="a">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="2"><subfield code="a">North America</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Vaccination</subfield><subfield code="x">adverse effects</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D014611Q000009</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Patient Care</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D005791</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Hépatite B</subfield><subfield code="x">Vaccination.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Vaccin anti-hépatite B.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Démyélinisation</subfield><subfield code="x">Vaccination.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Vaccination</subfield><subfield code="x">Complications et séquelles.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Politique sanitaire.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Démyélinisation.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Système nerveux</subfield><subfield code="x">Maladies.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Vaccins antiviraux.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Maladies.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Vaccins.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Contrôle social.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Sciences sociales.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Sociologie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Prestation de soins.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Produits biologiques.</subfield></datafield><datafield tag="651" ind1=" " ind2="6"><subfield code="a">Amérique du Nord.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Immunisation</subfield><subfield code="x">Complications et séquelles.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Soins médicaux.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médicaments biologiques.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">social sciences.</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">sociology.</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Pharmacology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Viral vaccines</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccines</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sociology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Social sciences</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Social control</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nervous system</subfield><subfield code="x">Diseases</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medical policy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medical care</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diseases</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Demyelination</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hepatitis B</subfield><subfield code="x">Vaccination</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hepatitis B vaccine</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunization</subfield><subfield code="x">Complications</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccination</subfield><subfield code="x">Complications</subfield><subfield code="2">fast</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">North America</subfield><subfield code="2">fast</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJxRHKPqWyj6g89H9PwHmd</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Andre fag (naturvidenskab og teknik)</subfield><subfield code="a">Andre fag</subfield></datafield><datafield tag="655" ind1=" " ind2="0"><subfield code="a">Electronic book.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stratton, Kathleen R.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n93803579</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Almario, Donna A.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n98091055</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McCormick, Marie C.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n98091060</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Immunization safety review (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCG8V97gpM96WHMKtKh7HBX</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Immunization safety review.</subfield><subfield code="d">Washington, D.C. ; [Great Britain] : National Academies Press, ©2002</subfield><subfield code="w">(DLC) 2003544621</subfield></datafield><datafield tag="856" ind1="1" ind2=" "><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=121296</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="1" ind2=" "><subfield code="l">CBO01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=121296</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBL - Ebook Library</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL3377265</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10068512</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">121296</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest MyiLibrary Digital eBook Collection</subfield><subfield code="b">IDEB</subfield><subfield code="n">18355</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">2293654</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Internet Archive</subfield><subfield code="b">INAR</subfield><subfield code="n">immunizationsafe0000unse_a2n1</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield></record></collection> |
genre | Electronic book. |
genre_facet | Electronic book. |
geographic | North America. http://id.loc.gov/authorities/subjects/sh85092455 United States North America Amérique du Nord. North America fast https://id.oclc.org/worldcat/entity/E39PBJxRHKPqWyj6g89H9PwHmd |
geographic_facet | North America. United States North America Amérique du Nord. |
id | ZDB-4-EBA-ocm70734600 |
illustrated | Illustrated |
indexdate | 2024-10-25T16:16:22Z |
institution | BVB |
isbn | 030956610X 9780309566100 1280183551 9781280183553 9786610183555 6610183554 0309182832 9780309182836 |
language | English |
oclc_num | 70734600 |
open_access_boolean | |
owner | MAIN |
owner_facet | MAIN |
physical | 1 online resource (xiv, 106 pages :) |
psigel | ZDB-4-EBA |
publishDate | 2002 |
publishDateSearch | 2002 |
publishDateSort | 2002 |
publisher | National Academies Press, |
record_format | marc |
spelling | Immunization safety review : hepatitis B vaccine and demyelinating neurological disorders / Kathleen Stratton, Donna A. Almario, and Marie C. McCormick, editors. Washington, D.C. ; [Great Britain] : National Academies Press, ©2002. 1 online resource (xiv, 106 pages :) text txt rdacontent computer c rdamedia online resource cr rdacarrier data file rda Includes bibliographical references (pages 85-90). Print version record. Use copy Restrictions unspecified star MiAaHDL Electronic reproduction. [S.l.] : HathiTrust Digital Library, 2010. MiAaHDL Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. http://purl.oclc.org/DLF/benchrepro0212 MiAaHDL digitized 2010 HathiTrust Digital Library committed to preserve pda MiAaHDL ""IMMUNIZATION SAFETY REVIEW""; ""Copyright""; ""Acknowledgments""; ""Contents""; ""Executive Summary""; ""ABSTRACT""; ""DEMYELINATING NEUROLOGICAL DISORDERS""; ""HEPATITIS B VIRAL INFECTION""; ""HEPATITIS B VACCINE""; ""EVIDENCE REVIEWED BY THE COMMITTEE""; ""CAUSALITY ASSESSMENT""; ""BIOLOGICAL MECHANISMS ASSESSMENT""; ""SIGNIFICANCE ASSESSMENT""; ""RECOMMENDATIONS FOR PUBLIC HEALTH RESPONSE""; ""Policy Review""; ""Research""; ""Surveillance""; ""Basic and Clinical Science""; ""Communication""; ""REFERENCES"" ""Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders""""THE CHARGE TO THE COMMITTEE""; ""THE STUDY PROCESS""; ""THE FRAMEWORK FOR SCIENTIFIC ASSESSMENT""; ""Causality""; ""Biological Mechanisms""; ""Terminology""; ""Categories of Evidence""; ""Published and Unpublished Data""; ""UNDER REVIEW: HEPATITIS B VACCINE AND DEMYELINATING NEUROLOGICAL DISORDERS""; ""Adverse Neurological Events""; ""Multiple Sclerosis""; ""Acute Disseminated Encephalomyelitis""; ""Optic Neuritis""; ""Transverse Myelitis""; ""Guillain-Barré Syndrome""; ""Peripheral Neuritis"" ""Hepatitis B Virus Infection and Hepatitis B Vaccines""""SCIENTIFIC ASSESSMENT""; ""Causality""; ""Case Reports""; ""Multiple Sclerosis""; ""Causality Argument""; ""First Episode of a Central Nervous System Demyelinating Disorder""; ""Acute Disseminated Encephalomyelitis""; ""Optic Neuritis""; ""Transverse Myelitis""; ""Brachial Neuritis""; ""Biological Mechanisms""; ""Immune-Mediated Processes in MS and Other Demyelinating White-Matter Diseases""; ""Theoretical Mechanisms for Infection-Induced Immune-Mediated Injury""; ""Theoretical Mechanisms for Vaccine-Induced Demyelinating Diseases"" ""Evidence from Animal Models for a Possible Role for Hepatitis B Vaccine in Demyelination""""Evidence from Humans""; ""Known Effects of Other Vaccines""; ""Conclusions Regarding Biological Mechanisms""; ""SIGNIFICANCE ASSESSMENT""; ""Disease Burden Associated with Multiple Sclerosis""; ""Hepatitis B Vaccine Safety Concerns in France""; ""Hepatitis B Virus Infection""; ""Prevention Strategies""; ""Acceptance of the Hepatitis B Vaccine in the United States""; ""Information on the Safety of the Hepatitis B Vaccine""; ""Conclusions""; ""RECOMMENDATIONS FOR PUBLIC HEALTH RESPONSE"" ""Policy Review""""Research""; ""Surveillance""; ""Basic and Clinical Science""; ""Communication""; ""SUMMARY""; ""REFERENCES""; ""Appendix A Committee Conclusions and Recommendations from Previous Reports ""; ""MEASLES-MUMPS-RUBELLA VACCINE AND AUTISM""; ""Conclusions""; ""Recommendations""; ""Public Health Response""; ""Policy Review""; ""Research Regarding MMR and ASD""; ""Communications""; ""THIMEROSAL-CONTAINING VACCINES AND NEURODEVELOPMENTAL DISORDERS""; ""Conclusions""; ""Public Health Response Recommendations""; ""Policy Review and Analysis"" English. Immunization to protect infants and children from vaccine-preventable diseases is one of the greatest achievements of public health. Immunization is not without risks, however. It is well established, for example, that the oral polio vaccine can on rare occasion cause paralytic polio.The Immunization Safety Review Committee was established by the Institute of Medicine (IOM) to evaluate the available evidence on a series of immunization safety concerns. The committee is charged with examining three immunization safety hypotheses each year during the three-year study period (2001- 2003). While all of the committee members share the view that immunization is generally beneficial, none of them has a vested interest in the specific immunization safety issues that come before the group. In this report, which is the fourth in the series, the committee examines the hypothesis that the hepatitis B vaccine increases the risk for demyelinating disorders of the central or peripheral nervous systems, including multiple sclerosis (MS) and Guillain-Barr syndrome (GBS). Hepatitis B Vaccination. http://id.loc.gov/authorities/subjects/sh85060296 Hepatitis B vaccine. http://id.loc.gov/authorities/subjects/sh85060297 Demyelination Vaccination. Immunization Complications. http://id.loc.gov/authorities/subjects/sh88000677 Vaccination Complications. http://id.loc.gov/authorities/subjects/sh85141710 Medical policy. http://id.loc.gov/authorities/subjects/sh85083002 Demyelination. http://id.loc.gov/authorities/subjects/sh85036687 Nervous system Diseases. http://id.loc.gov/authorities/subjects/sh85090924 Viral vaccines. http://id.loc.gov/authorities/subjects/sh85143735 Diseases. http://id.loc.gov/authorities/subjects/sh85038411 Vaccines. http://id.loc.gov/authorities/subjects/sh85141718 Social control. http://id.loc.gov/authorities/subjects/sh85123931 Social sciences. http://id.loc.gov/authorities/subjects/sh85124003 Sociology. http://id.loc.gov/authorities/subjects/sh85124200 Medical care. http://id.loc.gov/authorities/subjects/sh85082871 North America. http://id.loc.gov/authorities/subjects/sh85092455 Biologicals. http://id.loc.gov/authorities/subjects/sh90002675 Biological products. http://id.loc.gov/authorities/subjects/sh85014183 Hepatitis B Vaccines adverse effects Demyelinating Diseases etiology Health Policy Biological Products Demyelinating Diseases Hepatitis B Vaccines Public Policy Nervous System Diseases Viral Hepatitis Vaccines Social Control Policies Viral Vaccines Disease Americas. Policy Vaccines Geographic Locations. Social Control, Formal Health Care Economics and Organizations. Social Sciences Geographicals. Sociology Delivery of Health Care Complex Mixtures Anthropology, Education, Sociology and Social Phenomena. Chemicals and Drugs. Biological Factors United States North America Vaccination adverse effects https://id.nlm.nih.gov/mesh/D014611Q000009 Patient Care https://id.nlm.nih.gov/mesh/D005791 Hépatite B Vaccination. Vaccin anti-hépatite B. Démyélinisation Vaccination. Vaccination Complications et séquelles. Politique sanitaire. Démyélinisation. Système nerveux Maladies. Vaccins antiviraux. Maladies. Vaccins. Contrôle social. Sciences sociales. Sociologie. Prestation de soins. Produits biologiques. Amérique du Nord. Immunisation Complications et séquelles. Soins médicaux. Médicaments biologiques. social sciences. aat sociology. aat MEDICAL Pharmacology. bisacsh Viral vaccines fast Vaccines fast Sociology fast Social sciences fast Social control fast Nervous system Diseases fast Medical policy fast Medical care fast Diseases fast Demyelination fast Hepatitis B Vaccination fast Hepatitis B vaccine fast Immunization Complications fast Vaccination Complications fast North America fast https://id.oclc.org/worldcat/entity/E39PBJxRHKPqWyj6g89H9PwHmd Andre fag (naturvidenskab og teknik) Andre fag Electronic book. Stratton, Kathleen R. http://id.loc.gov/authorities/names/n93803579 Almario, Donna A. http://id.loc.gov/authorities/names/n98091055 McCormick, Marie C. http://id.loc.gov/authorities/names/n98091060 has work: Immunization safety review (Text) https://id.oclc.org/worldcat/entity/E39PCG8V97gpM96WHMKtKh7HBX https://id.oclc.org/worldcat/ontology/hasWork Print version: Immunization safety review. Washington, D.C. ; [Great Britain] : National Academies Press, ©2002 (DLC) 2003544621 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=121296 Volltext CBO01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=121296 Volltext |
spellingShingle | Immunization safety review : hepatitis B vaccine and demyelinating neurological disorders / ""IMMUNIZATION SAFETY REVIEW""; ""Copyright""; ""Acknowledgments""; ""Contents""; ""Executive Summary""; ""ABSTRACT""; ""DEMYELINATING NEUROLOGICAL DISORDERS""; ""HEPATITIS B VIRAL INFECTION""; ""HEPATITIS B VACCINE""; ""EVIDENCE REVIEWED BY THE COMMITTEE""; ""CAUSALITY ASSESSMENT""; ""BIOLOGICAL MECHANISMS ASSESSMENT""; ""SIGNIFICANCE ASSESSMENT""; ""RECOMMENDATIONS FOR PUBLIC HEALTH RESPONSE""; ""Policy Review""; ""Research""; ""Surveillance""; ""Basic and Clinical Science""; ""Communication""; ""REFERENCES"" ""Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders""""THE CHARGE TO THE COMMITTEE""; ""THE STUDY PROCESS""; ""THE FRAMEWORK FOR SCIENTIFIC ASSESSMENT""; ""Causality""; ""Biological Mechanisms""; ""Terminology""; ""Categories of Evidence""; ""Published and Unpublished Data""; ""UNDER REVIEW: HEPATITIS B VACCINE AND DEMYELINATING NEUROLOGICAL DISORDERS""; ""Adverse Neurological Events""; ""Multiple Sclerosis""; ""Acute Disseminated Encephalomyelitis""; ""Optic Neuritis""; ""Transverse Myelitis""; ""Guillain-Barré Syndrome""; ""Peripheral Neuritis"" ""Hepatitis B Virus Infection and Hepatitis B Vaccines""""SCIENTIFIC ASSESSMENT""; ""Causality""; ""Case Reports""; ""Multiple Sclerosis""; ""Causality Argument""; ""First Episode of a Central Nervous System Demyelinating Disorder""; ""Acute Disseminated Encephalomyelitis""; ""Optic Neuritis""; ""Transverse Myelitis""; ""Brachial Neuritis""; ""Biological Mechanisms""; ""Immune-Mediated Processes in MS and Other Demyelinating White-Matter Diseases""; ""Theoretical Mechanisms for Infection-Induced Immune-Mediated Injury""; ""Theoretical Mechanisms for Vaccine-Induced Demyelinating Diseases"" ""Evidence from Animal Models for a Possible Role for Hepatitis B Vaccine in Demyelination""""Evidence from Humans""; ""Known Effects of Other Vaccines""; ""Conclusions Regarding Biological Mechanisms""; ""SIGNIFICANCE ASSESSMENT""; ""Disease Burden Associated with Multiple Sclerosis""; ""Hepatitis B Vaccine Safety Concerns in France""; ""Hepatitis B Virus Infection""; ""Prevention Strategies""; ""Acceptance of the Hepatitis B Vaccine in the United States""; ""Information on the Safety of the Hepatitis B Vaccine""; ""Conclusions""; ""RECOMMENDATIONS FOR PUBLIC HEALTH RESPONSE"" ""Policy Review""""Research""; ""Surveillance""; ""Basic and Clinical Science""; ""Communication""; ""SUMMARY""; ""REFERENCES""; ""Appendix A Committee Conclusions and Recommendations from Previous Reports ""; ""MEASLES-MUMPS-RUBELLA VACCINE AND AUTISM""; ""Conclusions""; ""Recommendations""; ""Public Health Response""; ""Policy Review""; ""Research Regarding MMR and ASD""; ""Communications""; ""THIMEROSAL-CONTAINING VACCINES AND NEURODEVELOPMENTAL DISORDERS""; ""Conclusions""; ""Public Health Response Recommendations""; ""Policy Review and Analysis"" Hepatitis B Vaccination. http://id.loc.gov/authorities/subjects/sh85060296 Hepatitis B vaccine. http://id.loc.gov/authorities/subjects/sh85060297 Demyelination Vaccination. Immunization Complications. http://id.loc.gov/authorities/subjects/sh88000677 Vaccination Complications. http://id.loc.gov/authorities/subjects/sh85141710 Medical policy. http://id.loc.gov/authorities/subjects/sh85083002 Demyelination. http://id.loc.gov/authorities/subjects/sh85036687 Nervous system Diseases. http://id.loc.gov/authorities/subjects/sh85090924 Viral vaccines. http://id.loc.gov/authorities/subjects/sh85143735 Diseases. http://id.loc.gov/authorities/subjects/sh85038411 Vaccines. http://id.loc.gov/authorities/subjects/sh85141718 Social control. http://id.loc.gov/authorities/subjects/sh85123931 Social sciences. http://id.loc.gov/authorities/subjects/sh85124003 Sociology. http://id.loc.gov/authorities/subjects/sh85124200 Medical care. http://id.loc.gov/authorities/subjects/sh85082871 Biologicals. http://id.loc.gov/authorities/subjects/sh90002675 Biological products. http://id.loc.gov/authorities/subjects/sh85014183 Hepatitis B Vaccines adverse effects Demyelinating Diseases etiology Health Policy Biological Products Demyelinating Diseases Hepatitis B Vaccines Public Policy Nervous System Diseases Viral Hepatitis Vaccines Social Control Policies Viral Vaccines Disease Americas. Policy Vaccines Geographic Locations. Social Control, Formal Health Care Economics and Organizations. Social Sciences Geographicals. Sociology Delivery of Health Care Complex Mixtures Anthropology, Education, Sociology and Social Phenomena. Chemicals and Drugs. Biological Factors Vaccination adverse effects https://id.nlm.nih.gov/mesh/D014611Q000009 Patient Care https://id.nlm.nih.gov/mesh/D005791 Hépatite B Vaccination. Vaccin anti-hépatite B. Démyélinisation Vaccination. Vaccination Complications et séquelles. Politique sanitaire. Démyélinisation. Système nerveux Maladies. Vaccins antiviraux. Maladies. Vaccins. Contrôle social. Sciences sociales. Sociologie. Prestation de soins. Produits biologiques. Immunisation Complications et séquelles. Soins médicaux. Médicaments biologiques. social sciences. aat sociology. aat MEDICAL Pharmacology. bisacsh Viral vaccines fast Vaccines fast Sociology fast Social sciences fast Social control fast Nervous system Diseases fast Medical policy fast Medical care fast Diseases fast Demyelination fast Hepatitis B Vaccination fast Hepatitis B vaccine fast Immunization Complications fast Vaccination Complications fast |
subject_GND | http://id.loc.gov/authorities/subjects/sh85060296 http://id.loc.gov/authorities/subjects/sh85060297 http://id.loc.gov/authorities/subjects/sh88000677 http://id.loc.gov/authorities/subjects/sh85141710 http://id.loc.gov/authorities/subjects/sh85083002 http://id.loc.gov/authorities/subjects/sh85036687 http://id.loc.gov/authorities/subjects/sh85090924 http://id.loc.gov/authorities/subjects/sh85143735 http://id.loc.gov/authorities/subjects/sh85038411 http://id.loc.gov/authorities/subjects/sh85141718 http://id.loc.gov/authorities/subjects/sh85123931 http://id.loc.gov/authorities/subjects/sh85124003 http://id.loc.gov/authorities/subjects/sh85124200 http://id.loc.gov/authorities/subjects/sh85082871 http://id.loc.gov/authorities/subjects/sh85092455 http://id.loc.gov/authorities/subjects/sh90002675 http://id.loc.gov/authorities/subjects/sh85014183 https://id.nlm.nih.gov/mesh/D014611Q000009 https://id.nlm.nih.gov/mesh/D005791 |
title | Immunization safety review : hepatitis B vaccine and demyelinating neurological disorders / |
title_auth | Immunization safety review : hepatitis B vaccine and demyelinating neurological disorders / |
title_exact_search | Immunization safety review : hepatitis B vaccine and demyelinating neurological disorders / |
title_full | Immunization safety review : hepatitis B vaccine and demyelinating neurological disorders / Kathleen Stratton, Donna A. Almario, and Marie C. McCormick, editors. |
title_fullStr | Immunization safety review : hepatitis B vaccine and demyelinating neurological disorders / Kathleen Stratton, Donna A. Almario, and Marie C. McCormick, editors. |
title_full_unstemmed | Immunization safety review : hepatitis B vaccine and demyelinating neurological disorders / Kathleen Stratton, Donna A. Almario, and Marie C. McCormick, editors. |
title_short | Immunization safety review : |
title_sort | immunization safety review hepatitis b vaccine and demyelinating neurological disorders |
title_sub | hepatitis B vaccine and demyelinating neurological disorders / |
topic | Hepatitis B Vaccination. http://id.loc.gov/authorities/subjects/sh85060296 Hepatitis B vaccine. http://id.loc.gov/authorities/subjects/sh85060297 Demyelination Vaccination. Immunization Complications. http://id.loc.gov/authorities/subjects/sh88000677 Vaccination Complications. http://id.loc.gov/authorities/subjects/sh85141710 Medical policy. http://id.loc.gov/authorities/subjects/sh85083002 Demyelination. http://id.loc.gov/authorities/subjects/sh85036687 Nervous system Diseases. http://id.loc.gov/authorities/subjects/sh85090924 Viral vaccines. http://id.loc.gov/authorities/subjects/sh85143735 Diseases. http://id.loc.gov/authorities/subjects/sh85038411 Vaccines. http://id.loc.gov/authorities/subjects/sh85141718 Social control. http://id.loc.gov/authorities/subjects/sh85123931 Social sciences. http://id.loc.gov/authorities/subjects/sh85124003 Sociology. http://id.loc.gov/authorities/subjects/sh85124200 Medical care. http://id.loc.gov/authorities/subjects/sh85082871 Biologicals. http://id.loc.gov/authorities/subjects/sh90002675 Biological products. http://id.loc.gov/authorities/subjects/sh85014183 Hepatitis B Vaccines adverse effects Demyelinating Diseases etiology Health Policy Biological Products Demyelinating Diseases Hepatitis B Vaccines Public Policy Nervous System Diseases Viral Hepatitis Vaccines Social Control Policies Viral Vaccines Disease Americas. Policy Vaccines Geographic Locations. Social Control, Formal Health Care Economics and Organizations. Social Sciences Geographicals. Sociology Delivery of Health Care Complex Mixtures Anthropology, Education, Sociology and Social Phenomena. Chemicals and Drugs. Biological Factors Vaccination adverse effects https://id.nlm.nih.gov/mesh/D014611Q000009 Patient Care https://id.nlm.nih.gov/mesh/D005791 Hépatite B Vaccination. Vaccin anti-hépatite B. Démyélinisation Vaccination. Vaccination Complications et séquelles. Politique sanitaire. Démyélinisation. Système nerveux Maladies. Vaccins antiviraux. Maladies. Vaccins. Contrôle social. Sciences sociales. Sociologie. Prestation de soins. Produits biologiques. Immunisation Complications et séquelles. Soins médicaux. Médicaments biologiques. social sciences. aat sociology. aat MEDICAL Pharmacology. bisacsh Viral vaccines fast Vaccines fast Sociology fast Social sciences fast Social control fast Nervous system Diseases fast Medical policy fast Medical care fast Diseases fast Demyelination fast Hepatitis B Vaccination fast Hepatitis B vaccine fast Immunization Complications fast Vaccination Complications fast |
topic_facet | Hepatitis B Vaccination. Hepatitis B vaccine. Demyelination Vaccination. Immunization Complications. Vaccination Complications. Medical policy. Demyelination. Nervous system Diseases. Viral vaccines. Diseases. Vaccines. Social control. Social sciences. Sociology. Medical care. North America. Biologicals. Biological products. Hepatitis B Vaccines adverse effects Demyelinating Diseases etiology Health Policy Biological Products Demyelinating Diseases Hepatitis B Vaccines Public Policy Nervous System Diseases Viral Hepatitis Vaccines Social Control Policies Viral Vaccines Disease Americas. Policy Vaccines Geographic Locations. Social Control, Formal Health Care Economics and Organizations. Social Sciences Geographicals. Sociology Delivery of Health Care Complex Mixtures Anthropology, Education, Sociology and Social Phenomena. Chemicals and Drugs. Biological Factors United States North America Vaccination adverse effects Patient Care Hépatite B Vaccination. Vaccin anti-hépatite B. Démyélinisation Vaccination. Vaccination Complications et séquelles. Politique sanitaire. Démyélinisation. Système nerveux Maladies. Vaccins antiviraux. Maladies. Vaccins. Contrôle social. Sciences sociales. Sociologie. Prestation de soins. Produits biologiques. Amérique du Nord. Immunisation Complications et séquelles. Soins médicaux. Médicaments biologiques. social sciences. sociology. MEDICAL Pharmacology. Viral vaccines Social sciences Social control Nervous system Diseases Medical policy Medical care Diseases Demyelination Hepatitis B Vaccination Hepatitis B vaccine Immunization Complications Vaccination Complications Electronic book. |
url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=121296 |
work_keys_str_mv | AT strattonkathleenr immunizationsafetyreviewhepatitisbvaccineanddemyelinatingneurologicaldisorders AT almariodonnaa immunizationsafetyreviewhepatitisbvaccineanddemyelinatingneurologicaldisorders AT mccormickmariec immunizationsafetyreviewhepatitisbvaccineanddemyelinatingneurologicaldisorders |